Ligand validation:6V1A

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6V1A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6V1A_NAG_B_201	10%	82%	0.265	0.772	0.24	0.55	-	-	0	0	100%	0.9333
6V1A_NAG_A_201	7%	85%	0.353	0.817	0.2	0.54	-	-	0	0	100%	0.9333
6V1A_NAG_A_202	0%	89%	0.512	0.495	0.23	0.41	-	-	0	0	100%	0.9333
6BIZ_NAG_A_201	46%	78%	0.163	0.897	0.33	0.56	-	-	0	0	100%	0.9333
7NZE_NAG_AAA_201	45%	35%	0.152	0.885	0.85	1.78	-	4	0	0	100%	0.9333
6BIL_NAG_A_201	44%	87%	0.19	0.917	0.24	0.46	-	-	0	0	100%	0.9333
7NZF_NAG_AAA_202	37%	40%	0.148	0.846	0.57	1.8	-	3	0	0	100%	0.9333
6BIX_NAG_A_201	36%	77%	0.16	0.85	0.29	0.61	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.